|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2014), EMA (2015)) |
IUPAC Name ![]() |
N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-7-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
9325 | eliglustat |
Synonyms ![]() |
GENZ-112638 |
Comments |
The marketed formulation contains eliglustat tartrate (PubChem CID 52918379). |
Database Links ![]() |
|
CAS Registry No. | 491833-29-5 |
ChEMBL Ligand | CHEMBL2110588 |
GtoPdb PubChem SID | 187051837 |
PubChem CID | 23652731 |
Search Google for chemical match using the InChIKey | FJZZPCZKBUKGGU-AUSIDOKSSA-N |
Search Google for chemicals with the same backbone | FJZZPCZKBUKGGU |
Search PubMed clinical trials | eliglustat |
Search PubMed titles | eliglustat |
Search PubMed titles/abstracts | eliglustat |
Search UniChem for chemical match using the InChIKey | FJZZPCZKBUKGGU-AUSIDOKSSA-N |
Search UniChem for chemicals with the same backbone | FJZZPCZKBUKGGU |
Wikipedia | Eliglustat |